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PREFACE
The Expression and Role of Fibroblast Growth Factor Receptors in 
Xenopus laevis Regenerating Hindlimbs.
Name: Christopher Alan D’Jamoos 
University of Dayton, 1997
Limb regeneration is a complex phenomenon that occurs in amphibians such as,
urodeles and anurans. This complicated process has been well characterized
*
morphologically in the salamander and frog species. However, only recent studies have 
been aimed at the molecular and cellular level. In pursuing research to identify signals 
involved in the process of limb regeneration, I have used the Xenopus laevis system, 
since it is capable of regenerating limbs only during its tadpole stages and loses this 
ability as it approaches metamorphosis. This study provides a descriptive analysis of the 
expression of genes coding for Fibroblast Growth Factor Receptors (FGFRs) which have 
been recognized as key signals during both limb development and regeneration. In this 
study, we present the expression patterns of five FGFRs in pre-metamorphic 
(regenerating) and post-metamorphic (non-regenerating) hindlimb outgrowths resulting 
after amputation. Demonstrating differences in receptor expression, we devised 
functional studies using inhibitors and tissue transplantation to illustrate the importance 
of these signals during the limb regeneration process.
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REVIEW OF LITERATURE
Limb Regeneration: Models.
Some amphibians, in contrast to reptiles, birds and mammals have the ability 
to replace a severed limb. Spallanzani (1769) first reported that salamanders are 
capable of regeneration, the ability to restore an injured or amputated body part. 
Urodeles are amphibians that keep their tails; such as the newt Notophthalamus 
viridescens, and can regenerate an amputated limb during either their larval or 
adult life, whereas the anuran (tailless), such as the Xenopus laevis, can 
regenerate a limb only during its tadpole stages (Korneluk and Liversage, 1984). 
Although mammals have not been found to possess regenerative abilities, the 
process of limb regeneration in amphibians has been compared to tissue 
regeneration at the distal tips of the phalanges in both mice and humans and 
wound healing in mammals (Borgens, 1982; Ord & Stocken,1984; Reginelli et
al., 1995).
Limb regeneration and development demonstrate similar patterns.
The principles that regulate patterning of the regenerating limb may be 
similar to those involved in patterning during initial limb development (Cohn and 
Tickle, 1996). The first event in the regenerative process is the covering of the 
wound by specialized epithelial cells, which is a process known as wound 
healing. This process is extremely important to the manufacturing of the 
necessary signals that will be incorporated in the wound epithelium. It is well 
known that if this wound covering is prevented, either by covering the tissue with
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grafted tissue or by the insertion of the amputated limb into the gut, no 
regeneration occurs (Goss, 1956). Wound healing begins immediately after 
amputation and discontinues once the wound epithelium has formed its covering. 
Following wound epithelium formation, a blastema forms through the 
dedifferentiation of muscle, cartilage and nerve cells, and mesodermal tissues 
(original stump tissues) become undifferentiated mesenchymal cells (Driesch,
1902). This blastema then enlarges due to cellular proliferation and eventually 
the cells redifferentiate into specific tissues that reconstitute the amputated part
(Butler, 1933).
The basic similarity between limb regeneration and limb pattern development
is based on the formation of this blastema. The blastema resembles embryonic
cells present during normal limb development and has the capacity to differentiate 
into specialized cells. Muneoka and Bryant (1982) through transplantation 
experiments with the regenerating axolotl Amblystoma mexicanum demonstrated 
that the patterning mechanisms involved in the developing and regenerating limb
are similar. They were able to show that normal limbs formed from ipsilateral 
grafts of limb bud/limb bud and limb bud/blastema, but supernumerary limbs 
formed through contralateral grafts. This suggests that something common to 
both developing and regenerating limbs provide for the pattern signals to the 
limb. In the developing chick wing and the regenerating limb, epithelium tissue 
proliferates to form an apical ectodermal ridge (AER; developing wings/limbs) or 
a wound epithelium (also called epidermal cap in regenerating limbs) that caps
the wing/limb bud (Zwilling, 1955; Fallon and Lopez, 1994). It is this covering
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that signal the underlying cells to proliferate in both systems. The developing 
limb bud consists of mesenchymal cells that undergo proliferation and 
differentiation enabling the patterning and establishment of an entire limb 
(Chevallier et al., 1977; Geduspan and Solursh, 1992).
The regenerating blastema consists of dedifferentiated tissue that 
redifferentiates into mesenchymal tissue. Spallanzani (1769), Morgan (1901) and 
many others have indicated that skeletal elements formed during limb 
regeneration are histologically similar to those present in developing limbs. On 
the cellular level, ultrastructural studies provide similarities between the 
regenerating blastema and the embryonic limb bud (Bryant et al., 1971; Bryant et 
al., 1977; Muneoka and Bryant, 1982). Their findings also suggest that muscle 
differentiation follows similar patterns between development and regeneration in
limbs. However, differences exist at the molecular level. Tassava et al. (1993),
Estrada et al. (1993), and Tassava and Acton (1989) have recognized certain 
antigens: such as WE3, WE4 and WE6 expresses in the wound epithelium and 
have been functionally studied and believed to be involved in secretion and cell 
adhesion processes. WE3 and WE4 have been implicated as actin-binding 
proteins and WE6 has been identified as keratin. These proteins, although 
present, most likely are not the signals for initiating limb regeneration; thus, the 
search for the molecular signals responsible for triggering dedifferentiation and 
regeneration are currently being investigated.
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FGFs and FGFRs likely play roles in the regeneration process.
Fibroblast growth factors (FGFs) and FGF receptors (FGFRs) likely play roles 
in amphibian limb regeneration and pattern formation in development. Members 
of the FGF family have been found to be present in the newt wound epithelium 
(FGFR-1 and FGFR-2, Poulin, et al., 1993; Poulin, and Chiu, 1995) and 
mesenchyme (Hondermarck and Biolly, 1990; Boilly et al., 1991). These 
molecules also have been implicated in the function of the limb bud AER in 
vertebrate systems (Orr-Urtreger et al., 1991; Herbert et al., 1990). FGF-2 has 
been found to induce regeneration in the chick wing bud when applied locally to 
the amputation site (Taylor et al., 1994). Niswander et al. (1993) and Vogel et al. 
(1995) have demonstrated that in the absence of an AER (the ectodermal tissue 
which directs the growth of the normal limb/wing) in chick wing buds, FGF is 
capable of replacing AER function by inducing the process of growth and pattern 
formation. It is apparent that these signals have induction capability and may be 
the target signals that initiate the regeneration process.
Characterization of FGF and FGFRs.
The FGF family consists of at least ten related genes (FGF 1-FGF 10) that are 
classified on the basis of conserved coding sequences (Johnson and Williams, 
1993; Emoto et al., 1997). FGF is a small polypeptide (13 Kda) that was first 
isolated by Gospodarowicz (1974) and was shown to be mitogenic in 3T3 cells. 
Since then, FGF protein-receptor interactions have been recognized in a number
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of different mechanisms of action, such as, proliferation, differentiation, and 
mesoderm induction, which depend on the cell type and the receptors involved 
(Femig and Gallagher, 1994). This multifunctional characteristic of FGF is what 
distinguishes it from the other growth factor members (Johnson and Williams,
1993).
Most FGFs are secreted and affect target cells by binding to one of five 
known FGF receptors (FGFR1, FGFR2, FGFR3, FGFR4a and FGFR-4b) and 
eventually activates transcription factors that provide a nuclear response. The 
actual number of FGFs and FGFRs is actually much greater, since there are
alternative translation initiation sites for the FGF ligands and multiple alternative 
splicing forms of these receptors (Johnson et al., 1991).
A clarification of nomenclature for different FGF and FGFR became
necessary when discoveries of multivariant genes were recognized (Table 1). Our 
discussion will focus primarily on the five receptors because they will be the 
focus of our investigation. FGFR-1 was first isolated from chicken embryos 
using radiolabeled FGF-1 and FGF-2 (Lee et al., 1989). Since then, it has also 
been isolated from human; h2, h3, or fig (Dionne et al., 1990), in the mouse; 
designated fig as well (Mansukhani et al., 1990), and Xenopus-, xFGFR-1 (Musci 
et al., 1990). Following the discovery of these genes, FGFR-2 (Freisel and 
Dawid, 1991), FGFR-3 (Keegan et al., 1991), FGFR-4 (Partanen et al., 1991), 
and FGFR4b (Dr. I. Hongo, Japan-not published) have been cloned in these 
systems. There is approximately 50-75% sequence homology amongst these 
receptors. Moreover, the receptor sequence homologies between species are quite
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high: 98% between human/mouse and 88% human/XewopMS (Freisel and Maciag, 
1995, Patrie et al., 1995). FGFRs’ structure can provide clues to its binding 
affinities for specific ligands as well as their mode of action. Each receptor, has 
an intracellular tyrosine kinase located at its C-terminal that binds substrates. Its 
extracytoplasmic region contains a 14 amino acid kinase insert domain that has 
different binding affinities for FGFs based on the immunoglobulin (Ig)-like
domains (Johnson et al., 1991).
Alternative Splicing and Ligand Specificity
Structural variants of these receptors are produced through alternative splicing 
of their RNA transcripts and appear to occur in a cell and tissue specific manner 
(Table 1). The first loop may or may not be excised leaving two or three loop 
receptor variants proposing no alteration in binding, and at the present time has 
not been functionally characterized. The genes for FGFR-1, 2, and 3 contain 
three mutually exclusive and consecutive exons that encode the 3 ’ half of the last 
Ig loop (Robbie, 1995). When a FGFR contains three Ig-like domains it is called 
an alpha (a) type; if it has only the second and third loop it is designated beta (p);
and when it is missing a secretory signal it is called gamma (y; Johnson and
Williams, 1993). The Ig-like domain is the binding site for FGF ligands. 
Alternative splicing also results in structural differences in tyrosine kinase 
domains (Shi et al., 1993). FGFR-1, FGFR-2 and FGFR-4 have membrane bound
localization; whereas, FGFR-3 has been found to be localized in the nucleus of
breast epithelial cells (Johnston et al., 1995). Splice variants of FGFR-1 and
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FGFR-2 also have been identified that give rise to secreted protein forms of the 
extracellular ligand binding domain (Freisel and Maciag, 1995).
FGFs are known to exert their effects through high affinity binding to 
receptors on the surface of cells (Dohrman et al, 1993). These proteins can bind 
to multiple receptors with different binding affinities, allowing for tissue specific 
regulation in response to FGF action. FGF binding is accomplished with the aid 
of proteoglycans, namely heparin, heparinase and heparin sulfate (HS) (Gao and 
Goldfarb, 1995; Itoh and Sokol, 1994; Kan et al., 1993). These molecules act to 
bind several FGF ligands, forming a web that cross-links and dimerizes receptors. 
The binding site for HS-FGF on FGFRs spans the second to approximately half 
the third loop and has no variant forms; whereas, loop III has three receptor 
forms: Ilia. Illb, and IIIc (Spivak-Kroizman, 1994). A receptor that only
contains Ilia, thus a Ilia variant, is a secretor variant, while those variants that
differ in their Illb and IIIc combinations provide an alteration in binding 
specificity for ligands . The activation of FGF on cells also can be accomplished 
by membrane bound low affinity glycosaminoglycan co-receptors (GAG) that are 
composed of a linear heteropolysaccaride bound to a proteoglycan with its sugars 
sulfated providing high charges (Jackson et al., 1991).
FGFR Signaling.
The signaling pathway and activation of these FGF receptors involves ligand- 
receptor binding (Patrie et al., 1995). Binding of a ligand causes the receptors to 
dimerize, initiating a conformational change that results in the activation of
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protein tyrosine kinase (PTK) The protein kinase domains phosphorylate each 
other to initiate downstream signaling (Burgess and Maciag, 1989). Every point 
in this system is crucial to the activation of transcription factors. If the ligand 
does not bind, most signals are discontinued. Dimerization has been recognized 
as important in catalytic events. The complexity of regulation of FGFRs comes 
from differences in their catalytic domains (Shi et al., 1993). There are two forms 
of FGFR, one with a full catalytic kinase domain (form 1), and the other with a 
truncated catalytic domain (form 2; Spivak-Kroizman, 1994). When 1-1 Forms 
dimerize catalytic domains are fully functional, 2-2 dimers are silent, and 1-2 
pairs are relatively inactive, although some have slight action (Shi et al., 1993). 
Since we will be using the tyrosine kinase domain as a point of manipulation to 
functionally inhibit FGFR signaling, it is important to describe the structure and 
pathways of these PTK groups.
Protein kinases impart their activity by binding or orienting their substrate 
site (intracellular receptor protein region with a Src homology 2 domain (SH2) 
with a phosphate donor that is either ATP or GTP complexed with a cation (Mg+^ 
or Mn++; Amaya et al., 1991). A phosphate is then transferred from the donor to 
the hydroxyl acceptor residue (serine, threonine, or in the case of FGFRs, 
tyrosine) of the substrate (Yaish et al., 1988). There are two general classes of 
PTK’s: the receptor tyrosine kinase that contains an extracellular ligand binding 
and intracellular calalytic domain with intrinsic kinase activity, and the receptor 
associated tyrosine kinase that transmit signals from the membrane receptor by 
interacting with cytoplasmic membrane proteins (Freisel and Maciag, 1995).
8
Three signaling processes are currently known to occur in PTK systems. The 
first pathway involves autophosphorlyation triggering the Ras and the MAP 
kinase cascade eventually initiating transcription factors that regulate genes
involved in the cell cycle (Haung et al., 1995; Johnson and Williams, 1993).
This pathway has been mostly found to be characteristic in cell proliferation and 
tumor formation. A second PTK pathway involves the activation of a G-protein 
which stimulates phospholipase C (PLC) to splits phosphatidylinositol 4,5- 
biphosphate (PIP2) into two second messengers: inositol 1,4,5-triphospate (IP3) 
and diacylglycerol (DAG; Shilling et al., 1994). This process eventually leads to
the release of calcium and the activation of protein kinases on the receptor 
processes. Since this pathway involves the use of secondary messengers, it most 
likely involves differentiation (Femig and Gallagher, 1994). The third pathway 
causes the phosphorylation of the statl transcription factors and allows protein
translocation into the nucleus. This method of PTK signal transduction has not 
yet been characterized with function for FGF processes, but is probably also 
involved in the regulation of the cell cycle, cell growth and differentiation 
(Mckeehan and Kan, 1994). A major phosphorylation site on FGFR-1 is Tyr766
at the carboxy terminus. This site has also been identified as the src homology
(SH) 2 domain in PLC (Ryan and Gillespie, 1994). Another major
autophosphorylation site has been localized at Tyr653 and is phosphorylated by 
intermolecular mechanisms, as opposed to the intramolecular activation of 
Tyr766 (Hou et al., 1993).
9
FGFR Inhibitors.
Recently, commercial companies (Calbiochem, La Jolla, Ca. and Sugen Inc., 
San Francisco, Ca) and researchers have developed kinase inhibitors to 
understand these signaling pathways and how they affect cell regulation. There 
are two groups of competitive inhibitors aimed at two areas in the signaling 
processes. One group of inhibitors acts on the catalytic domain by using a 
pseudosubstate sequence to prevent substrate interactions and the other group acts 
on the regulatory domains by blocking the activity of ATP/GTPase either through 
binding to the regulatory domain or inhibiting cofactor binding (Levitzki, 1990). 
The difficulty with using these inhibitors to evaluate function is that they 
sometimes affect other processes through non-specific actions on a given system
in vivo.
Tyrophostin-A23 (3,4-dihydroxybenzylidene malononitrile; figure 1 A) is a 
potent and broad ranged PTK inhibitor that primarily focuses on epidermal 
growth factor; however, it has been found that Tyrophostin A-23 is unstable in 
solution and that its derivatives are potent src tyrosine kinase inhibitors (Ramdas 
et al., 1995). In vitro experimentation has shown these derivatives to be an 
effective inhibitor of FGF receptor activity at a Ki (concentration constant) of 20-
35 pM, EGF receptor at a Ki of 45 pM as well as others reviewed by Ramdas et
al. (1995). These derivatives as well as Tyrophostin A-23 act by competitively 
inhibiting the substrate site of the tyrosine kinase receptor.
Oxindole-based compounds (also called Indolinones) are a new class of 
protein tyrosine kinase inhibitors that demonstrate the ability to inhibit the
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tyrosine kinase action of FGFR-1, PDGF (Mohammadi et al., 1997) and FGFR-2 
(McMahon, Sugen, Inc. San Francisco, Ca., 1997-unpublished). SU4984 (3-(4- 
(l-formylpiperazine-4-yl)-benzylidenzyl)-2-indolinone; figure IB) blocked the
tyrosine kinase activity of the FGFR in 3T3 NIH cells at a Ki of 20-40pM as well 
as platelet derived growth factor and the insulin receptor, but not the epidermal
growth factor (Mohammadi et al., 1997). Oxindole based inhibitors, namely
SU5402, SU4984, SU76516, SU76568 and SU76636 were given to us by Dr.
McMahon from Sugen, Inc. in California. SU76516, SU76568 and SU76636 have
not been characterized to date, but their inhibition is believed to be much more
specific to FGFR-1 and FGFR-2 than SU4894 and SU5402 has been
demonstrated strongly and specifically inhibit FGFRs at a concentration between
10-20pM (McMahon, unpublished and Mohammadi et al., 1997). Indolinones
act to inhibit the kinase activity of FGFR-1, affecting the catalytic (competitive
inhibitor of the ATP site) domain of the receptors.
FGFRs involvement in various human diseases.
FGFR have been identified in various human diseases involving limb and
craniofacial development. A mutation in FGFR-1 can cause Pfeifer syndrome
that is characterized by limb defects and abnormal skull and facial shape due to 
premature differentiation of cartilage and bone (Cross and Dexter, 1991). FGFR- 
2 has been identified as the gene responsible for Crouzon, Jackson-Weiss, and 
Apert syndromes (Su, 1997; Bellus et al., 1995). All of these syndromes are 
caused by gene mutations altering normal development and causes limb and facial
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defects (Park et al., 1995). Mutations in FGFR-3 can cause achondroplasia 
resulting in dwarfism which can be lethal (Bellus et al., 1995; Tavormina, 1995). 
In these cases, FGFR appears to be turned on, without the necessity of a signal or 
FGF ligand, preventing cartilage growth. However, when FGFR-3 gene knockout 
in mice was performed, and expansion of endochondrial growth occurs, 
suggesting that other mechanisms and genes are involved (Su, 1997).
FGF and FGFR expression and action in limb development.
In the developing chicken limb bud, FGF signals from the AER are necessary 
for normal outgrowth and patterning of the limb (Niswander et al., 1993). FGFs 
are believed to be the mitogenic signal present in the AER that induces cells to 
differentiate during limb development. When chick limb mesenchyme is placed 
in cell culture at clonal density with FGF-2, muscle differentiation increases and 
the terminal differentiation of myoblasts is inhibited (Goldfarb, 1991). As 
growth of the limb occurs in vivo, posterior cells are the first to leave the area 
under the AER (progress zone) and to differentiate. These cells migrate in a 
proximal to distal direction. When the AER is removed, cell growth is inhibited, 
however, when FGF-2 (also called bFGF) or FGF-4 is introduced to these limb 
bud cells, growth continues (Fallon et al., 1994; Niswander et al., 1993). When 
beads soaked in FGF 1,2, and 4 were placed in the lateral plate mesoderm 
opposite somites 20-26 in chick embryos, they were stimulated to produce 
additional limbs (Cohn et al., 1995). FGF-8 is believed to be involved in 
mitogenesis, signaling for the proliferation of the underlying mesenchymal cells,
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causing limb elongation (Crossley et al., 1996; MacArthur et al., 1995; Mahmood
et al., 1995; Vogel et al., 1996).
The developing mouse has been shown through \n situ hybridization studies 
to express FGFR-1 (fig) and FGFR-2 (bek) mRNA in the lateral mesoderm and
the limb bud mesenchyme (Orr-Urtreger et al., 1991). bek appeared to be 
localized in the surface ectoderm and chondrocytes in the developing limb 
expressing strongest in the interdigital web, whereas fig seems to be distributed in 
the mesenchyme. FGFR-3 expression appears to be primarily found in the 
cartilage rudiments of developing bone, around the periosteum during
endochondrial ossification and in resting cartilage (Peters et al., 1993). Northern
blot expression studies demonstrated that FGFR-4 appears to be moderate in fetal 
human striated muscle, pancreas and adrenal gland (Partanen et al., 1991; Stark et 
al., 1991). Only FGFR-4 can be induced by heparin alone to dimerize and
autophosphoryl ate; however, the role of heparin to induce physiological changes
is still uncertain (Femig and Gallagher, 1994). Newborn mice that were
transgenic for FGFR-1 were bom without lungs (Park et al., 1995; Herbert et al..
1990). These studies demonstrate that FGF and its receptors are expressed in a
tissue specific manner and that it is crucial to understand how they relate to the
developmental process.
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FGF and FGFR presence in limb regeneration.
Related to the roles of FGFs in limb development, the presence of FGF and its 
receptors has been studied during limb regeneration processes in the axolotl 
Amblystoma mexicanum and in the newt, Notophthalmus viridescens, to ascertain 
FGF’s role. In the axolotl, FGF-1 has been found to be present in the wound 
epithelium and the mesenchyme (Boilly et al., 1991; Hondermarck and Boilly, 
1990) and its receptor-ligand binding is heparinase sensitive (Forough et al.,
1991; Itoh and Sikol, 1994). FGF receptors have been found to be spatially and 
temporally distributed in a specific manner in the regenerating newt limb (Poulin 
et al., 1993). During the blastema stages of regeneration, FGFR2 expression is 
localized in the wound epithelium basal layer and in the perichondrium (bone cell 
precursors). Alternative spicing of FGFR2 produces two different transcripts, 
KGFR and bek. These two isoforms delineate more specific expression patterns 
present during the stages of regeneration associated with growth and blastema cell 
proliferation. These transcripts differ in the second half of the third Ig-like loop 
domain, and their expression is present in different tissues at different times in the 
regeneration process. In the pre-blastema stage, the KGFR mRNA transcript is 
present only in the basal layer of the wound epithelium, whereas the bek 
expression is first presented in the perichondrium, then as regeneration progresses 
its presence is in the mesenchyme. In contrast, FGFR1 was expressed
exclusively in the blastema mesenchymal cells (Poulin et al., 1993; Poulin and
Chiu, 1995).
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Xenopus laevis offers a system to study limb regeneration.
Although the newt has been an exceptional model system to study the limb 
regeneration, Xenopus laevis limb regeneration only exists during the early 
tadpole stages and loses this ability after metamorphosis. In 1962, Dent has 
described the process of Xenopus limb regeneration in detail, providing evidence 
that as Xenopus increases in age, it loses its ability for complete regeneration.
The later the amputation takes place during its tadpole stages the more incomplete 
the regeneration. If the animal is amputated postmetamorphically (stage 59 and 
older), it only forms a cartilagenous (hypomorphic) spike; therefore, this system 
offers us a means to discriminate those signals that no longer are present when 
regenerative ability is lost.
Limb patterning and regeneration in the Xenopus laevis hindlimb.
Since staging the animals for limb regeneration is crucial to our experiments, 
it is necessary to briefly describe the developmental process of the limb in 
Xenopus laevis in accordance to Nieuwkoop and Faber (1976). In its early stages, 
specifically stages 48 through 50 (approximately 7.5-16 days after fertilization), 
the hindlimb becomes apparent as a semicircular bud with a conical definition on 
its distal side. At stages 51 through 53 (approximately 17-25 days post­
fertilization), the hindlimb becomes more cone-like and paddle shaped with slight 
indications of a flat foot, increasing in length rather than width. It is at this 
developmental stage that the limb becomes pigmented, forming melanophores,
15
and develops a 4th and a 5th toe. This is the point at which amputation would 
provide complete limb regeneration. At stages 54 through 59 (26-45 days post­
fertilization), the tadpole hindlimb grows to its full nature. Xenopus laevis, 
during its normal and final stages of limb development, grows 3 black clawed 
digits, and the fourth and fifth digits remain unclawed. The limb being extremely 
small and delicate is not the only indicator in the staging process. The tentacles 
are also helpful in aging the tadpoles, because they become longer at the end of 
stage 53 and decreased in length as they approached metamorphosis at the end of 
stage 59.
The anuran process of regeneration after a mid-shank amputation at stage 53 to 
55 (Nieuwkoop and Faber. 1976) follows that of normal urodele (newt) 
regeneration: wound covering, dedifferentiation, cell proliferation, 
redifferentiation and maintenance of growth, and termination of growth (Butler, 
1933). As mentioned above, the wound epithelium is considered to be the initiator 
of the regeneration process by providing the signal to cells underneath it to
dedifferentiate and form a blastema (Stocum, 1984; Tsonis, 1996). We believe
that FGF and FGFR are likely candidates for such signals.
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Research Objectives.
This comparative study between regenerative (pre-metamorphic) and non-
regenerative (post-metamorphic) stages that are present during Xenopus laevis
hindlimb regeneration was designed to pinpoint possible factors that might
initiate the limb regeneration process and lead us toward discovering the
mechanisms involved in tissue regeneration in vertebrates. We therefore,
examined the expression of five FGFRs during Xenopus laevis ’ pre-metamorphic
stages (tadpole stages); a developmental time in which limb regeneration is
permissive, and post-metamorphic stages (froglet stage); a period in which this
ability is lost, in order to correlate expression patterns with regenerative ability.
Here, we conclusively show that expression does relate to the regulation of this
process. We have further studied the role of these receptors by using specific
inhibitors. Our study implicates FGFR-1 and FGFR-2 as the major players, which
regulate the ability for limb regeneration.
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Fibroblast Growth Factor Receptors Regulate the Ability For Hindlimb 
Regeneration in Xenopus laevis.
Christopher Alan D’Jamoos
Department of Biology, University of Dayton, OH 45469-2320
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ABSTRACT
During outgrowth of the developing limb, signals from the apical ectodermal 
ridge (AER), such as Fibroblast Growth Factors (FGF), are paramount for limb 
patterning. Similarly, FGF molecules and their receptors are synthesized in the 
wound epithelium of the regenerating limb blastema, implicating an analogous 
function to limb development. To address this issue further and to fathom the role 
of FGFR signaling in limb regeneration, we have examined the expression 
patterns of xFGFR-1, xFGFR-2, xFGFR-3, xFGFR-4a and xFGFR-4b in Xenopus 
laevis. This amphibian model provides a system where both regenerating (pre- 
metamorphic; tadpole or larva stage) and non-regenerating (post-metamorphic; 
froglet stage) hindlimbs can be studied. In pre-metamorphic hindlimbs 
(stage 53) all the receptors were expressed in the wound epithelium and the 
underlying mesenchyme. In post-metamorphic limbs (stage 61), however, 
transcripts for xFGFR-1 and xFGFR-2 were absent from the wound epithelium. 
The expression results for xFGFR-1 and xFGFR-2 were corroborated at the 
protein level by employing specific antibodies. Thus, it appears that both 
FGFR-1 and FGFR-2 are the prime candidates involved in the outgrowth 
signaling during the regeneration process. FGFRs role in regeneration was 
further investigated by using specific inhibitors to FGFRs during pre- 
metamorphic regeneration. These compounds inhibited the normal limb 
outgrowth and resulted in the majority of the cases, to generate cones and spikes 
reminiscent of growth that is seen in amputated post-metamorphic limbs. Lastly, 
since the FGFR signals expression differences are derived from the wound
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epithelium, we have preliminary results demonstrating the successful
transplantation and conversion of post-metamorphic limbs to recapture their 
regenerative ability. These results are discussed in relation to future regenerative 
models and the possibilities of inducing regeneration in non-regenerative systems.
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INTRODUCTION
Urodeles and anurans are two commonly used systems to study limb
regeneration. Urodeles, such as the newt Notophthalmus viridescens can
regenerate an amputated limb during either its larval or adult life (Tsonis, 1991),
whereas the anuran Xenopus laevis can regenerate its limb only during the tadpole
stage (Bossilico et al., 1992; Korneluk and Liversage, 1984). The first event in the
regenerative process is the covering of the wound by specialized epithelial cells,
then the muscle, cartilage, nerve cells and mesodermal tissues become
undifferentiated mesenchymal cells forming a blastema (Driesch, 1902). This
blastema then enlarges due to cellular proliferation and eventually redifferentiates
into specific tissue cells that reconstitute the amputated part (Butler, 1933; Tsonis,
1996). Xenopus laevis ’ intrinsic ability for limb regeneration during stage 52-55
(pre-metamorphic; stages delineated according to Nieuwkoop and Faber, 1976)
discontinues at the onset of metamorphosis at stage 59 (post-metamorphic). At
this stage of development, the limb is non-regenerative and grows a cartilagenous
stump. Although the newt has been an excellent model to study limb regeneration,
Xenopus laevis offers a system containing both regenerative and non-regenerative
limb capacities, therefore, it can be used to comparatively reveal differences in
signal presence or specific gene expression correlated with the ability for limb
regeneration.
Fibroblast Growth Factors (FGFs) and FGF receptors (FGFRs) could provide 
signals that might play a crucial role in limb regeneration and pattern formation.
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The FGF family consists of at least ten related genes (FGF 1-FGF 10; reviewed in 
Johnson and Williams, 1993; Emoto et al., 1997) and are small polypeptides («13 
Kda, Gospodarowicz, 1974). Most FGFs are secreted and affect target cells by 
binding to one of five known FGF receptors (xFGFR-1, xFGFR-2, xFGFR-3, 
xFGFR-4a and xFGFR-4b). Members of the FGF family and their receptors are 
present in the wound epithelium (Boilly, B. 1991; Poulin et al., 1993; Poulin and 
Chiu, 1995). Although their regulatory roles for limb outgrowth and patterning in 
regeneration are not fully understood, evidence has been presented from other 
systems and imply that FGFs are imperative signals for this process. In 
particular, during chick limb bud development, signals from the apical ectodermal 
ridge (AER; the equivalent of the wound epithelium during newt limb 
regeneration) are responsible for supporting limb outgrowth. Removal of the 
AER inhibits limb development, but when FGF soaked beads are added into 
AER-less limb buds, outgrowth is restored (Niswander et al., 1993). Therefore, 
by analogy, these factors could be the important factors for the initiation of the 
limb regeneration process as well.
Several studies using the axolotl, Amblystoma mexicanum, and the newt, 
Notophthalmus viridescens, have shown the presence of FGFs and FGFRs in the
wound epithelium during limb regeneration (Boilly et al., 1991; Poulin and Chiu;
1995). FGF-1 (aFGF) and FGF-2 (bFGF) were found to be present in the wound 
epithelium (epidermal cap) and the blastema in the regenerating limbs of the
axolotl (Biolly et al., 1991). These FGF receptors have been found spatially and
temporally distributed in a specific manner in the regenerating newt limb (Poulin
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et al., 1993; Poulin and Chiu, 1995). During the blastema stages of regeneration, 
nvFGFR2 expression is localized in the wound epithelium basal layer and in the 
perichodrium (bone cell precursors). In contrast, nvFGFRl was expressed 
exclusively in the blastema mesenchymal cells (Poulin and Chiu, 1995). This 
expression is consistent with the idea that FGF might be in the wound epithelium 
and involved in the signaling for limb outgrowth during regeneration.
The primary objective of this research project was to determine the expression 
patterns of FGFRs during limb regeneration in Xenopus laevis, which loses the 
ability to regenerate its limbs after metamorphosis. Therefore, this system can 
reveal differences in growth factor presence and action. For this, we have 
selected five FGFRs cloned from Xenopus laevis and we have examined their 
expression via in situ hybridization and by immunofluorescence. Having 
correlated expression of two receptors (xFGFR-1 and xFGFR-2) with the ability 
for limb regeneration, we examined the input of their function by using specific 
inhibitors. In addition, we will also present data demonstrating induction of limb 
regeneration in stage 61 (post-metamorphic and non-permissive) amputated 
froglet host limbs when the wound epithelium from stage 53-55 (pre- 
metamorphic and permissive) is transplanted.
MATERIALS AND METHODS
Reagents
Unless otherwise specified, all materials were analytical reagents of the 
highest grade commercially available from Acros Organics (Princeton, NJ), 
Aldrich Chemical Company (Milwaukee, WI), Atlanta Biochemicals (Norcross, 
GA), Boehringer Mannheim (Indianapolis, IN), Fisher Scientific (Pittsburgh, 
PA), Miles, Inc.(Indianapolis. IN), Oxford Labware (St. Louis, MO), Sigma 
Chemical Company (St.Louis, MO), and Vector Laboratories (Burlingham, CA),
and were used without further purification.
Animals
Laboratory bred tadpoles were purchased from Xenopus One Inc., WI and 
kept at room temperature in dechlorinated tapwater (One drop Stress-Coat 
Aquarious Water Conditioner, lml/lgal mixed with food, Aquarious 
Pharmaceuticals, Inc, PA) maintained under oxygenation. The animals were put
on a twelve hour light cycle and were fed two to three times daily. The feeding 
and cleaning procedure were as follows. 1. Tanks were cleaned every other day 
by brush and fresh tap water. While the animals were netted, the tank was filled 
with de-chlorinated tap water to give the animals an inch of swimming room. 2. 
Two teaspoons of powdered food (provided by Xenopus-One, MI) were added to 
a 1 L blender filled with 250ml tap water with the inclusion of a drop of
dechlorinator. The mixture was then blended to a uniform color or until all
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granules dissipated. 3. This mixture was then added to each tank until the tank
was barely cloudy.
Tadpoles were staged prior to amputation according to Nieuwkoop and Faber 
(1976) for each experiment. A total of 100 tadpoles were used in the expression
studies and 140 for inhibitor studies. Tadpoles were amputated at stages 53 (pre- 
metamorphic) at which regeneration is possible and stage 61 (post-metamorphic), 
when amputation produces a cartilagenous spike. At the correct stages, tadpoles 
were anaesthetized using 1% 3-aminobenzoic acid ethyl ester (Sigma Chemical 
Company) or by submerging animals in chilled water (3-6° C) prior to dissection.
Due to the delicate nature and small size of the limbs, a surgical scalpel and
diamond sharp forceps (Roboz Surgical Instruments Company, Inc., MD) were
used to remove the presumptive ankle region of the hindlimb in the early tadpoles
and to remove tissue below the knee in the post-metamorphic limb. Tissues for
expression studies were then collected and fixed at 3 days, 10 days and 15 days 
post-amputation. Animals that were used for inhibitor studies were sacrificed
after a period of 23 days.
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Probes
xFGFR-1
Received from: Robert Freisel, Red Cross Laboratories, Maryland 
Vector: pBluescript SK DH5alpha 
Antibiotic Resistance: Ampicillin 
Cloned in BamHl site
Antisense Promotor: T3 Digested With: Xhol
Sense Promotor: T7 Digested With: Xbal
Genbank Accession number: M55163
xFGFR-2
Received from: Robert Freisel, Red Cross Laboratories, Maryland 
Vector: pBluescript SK DH5alpha 
Antibiotic Resistance: Ampicillin 
Cloned in BamHl site
Antisense Promotor: T7 Digested With: Notl or Xba 
Sense Promotor: T3 Digested With: Kpnl or Xhol 
Genbank Accession number: MM62322
xFGFR-3
Received from: Dr. Ikuko Hongo Dr. H. Okamoto, Ibaraki, Japan 
Vector: pBluescript II SK- DH5alpha 
Antibiotic Resistance: Ampicillin 
Cloned in EcoRV
Antisense Promotor: T3 Digested With: AccI
Sense Promotor: T7 Digested With: Notl
Genbank Accession number: AB007035
xFGFR-4a
Received from: Dr. Ikuko Hongo Dr. H. Okamoto, Ibaraki, Japan 
Vector: pBluescript II SK- DH5alpha 
Antibiotic Resistance: Ampicillin 
Cloned in EcoRV
Antisense Promotor: T3 Digested With: Hind III
Sense Promotor: T7 Digested With: Xbal
Genbank Accession number: AB007036
xFGFR-4b
Received from: Dr. Ikuko Hongo & Dr. H. Okamoto, Ibaraki, Japan 
Vector: pBluescript II SK- DH5alpha 
Antibiotic Resistance: Ampicillin 
Cloned in EcoRV
Antisense Promotor: T7 Digested With: BamHl
Sense Promotor: T3 Digested With: Hindlll
Genbank Accession number: AB007036
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In situ hybridization
200 limbs that were used for expression studies were processed for paraffin
embedding using in situ hybridization precautions because it is extremely
important to keep all samples sterile of contamination, since any RNAse will
confound these experiments. All tools and glassware were either autoclaved or
baked and all solutions were either autoclaved or filtered. Tissues were first
rinsed in a 1:1 lx phospate-buffered-saline, pH 7.2 (PBS)/diethyl pyrocarbonate
(DEPC Acros, Princeton) then fixed in 4% paraformaldehyde in PBS (4°C)
overnight. Tissues were dehydrated through an alcohol series (30, 50, 70, 80, 95,
100%), cleared in Hemo-D (Fisher Scientific, Pittsburgh), then coated and
embedded in molten paraplast (Oxford Labware, St. Louis). Six-microns-thick
sections were cut using a Spencer model “ 820” microtome (Fisher Scientific),
allowed to spread in pre-warmed DEPC, and mounted on vectabond (following
company’s protocal; Vector laboratories, Burlingham) pretreated and cleaned
slides. These sections were melted on a slide warmer at 45°C for 30 minutes and
kept at 4°C until ready for use.
The sections were processed for in situ hybridization using protocols provided
by the Boehringer Mannheim (Indianapolis) Digoxygenin (DIG)-labeled RNA
method with slight modifications according to Furlow et al. (1997). Plasmids
containing FGFR genes were digested with the appropriate restriction enzymes.
Riboprobes (both antisense and sense- see above) were made using either T7,
Sp6 or T3 RNA polymerase and labeled using the DIG RNA kit from Boehringer-
Mannheim. Slides were placed on a slide warmer (45°C) for 20 minutes, then
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dewaxed in Hemo-D (Fisher-Scientific) until paraffin was removed. All
solutions were made in DEPC water unless otherwise stated. Slides were
rehydrated in an ethanol series then post-fixed in 4% paraformaldehyde (room
temperature, pH 7.2) and digested with 250 pg/ml pepsin on a slide warmer
(37° C) for 7 to 12 minutes. The slides were then fixed again in 4%
paraformaldehyde for 10 minutes and washed in lx PBS/DEPC. Sections were
then acetylated in 0.25% acetic anhydride in trichloroethanolamine (pH 8.0) for
10 minutes and washed again in lx PBS/DEPC. Tissues were rehydrated in an
ethanol series and allowed to dry on a slide warmer at 45° C . Antisense and
sense DIG labeled probes were diluted to 1000-1500 ng/ml with hybridization
solution (50% Formamide, ImM EDTA, lOmM Tris/HCl pH 7.5, 600 mM NaCl,
0.25%SDS, 10% PEG 6000, lx Denhardt’s solution and 200 ug/ml yeast tRNA)
and heat denatured at 85°C for 5 minutes. Probes were incubated with sections in
separate moist chambers (sense and antisense groups) and kept at 60°C overnight
(16 hours). The next day, all washes took place at 55°C in a water bath with the
exception of 5x SSC. First, slides were washed at 5xSSC briefly, then treated in
RNase solution (Fisher-Scientific) for 30 minutes and washed in 2xSSC for 1
hour and O.lxSSC for an additional hour. The slides were briefly rinsed in buffer
1 (0.1M Tris/HCl pH 7.6, 0.15 M NaCl) for 5 minutes. The slides were blocked
in buffer 2 (0.1M Tris/HCl pH 7.6, 0.15 M NaCl made with 10% heat inactivated
horse serum) for 1 hour. They were then incubated for 2 hours with anti-DIG
antibody conjugated to alkaline phosphatase (Boehringer-Mannheim) prepared in
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buffer 2 which was modified to 1% heat inactivated horse serum in a humidified
chamber of buffer 1. Slides were not allowed to dry throughout the entire
immunological detection procedure. Slides were then washed 4x at 5 minutes in
buffer 1 and incubated 10 minutes in buffer 3 (lOOmM Tris/HCl pH 9.5, lOOmM
NaCl, 50mM MgCf) and developed in NBT/BCIP (nitroblue
tetrazolium/bromochloroindoylphosphate from Boehringer-Mannheim) for 2-18
hours.
Immunofluorescence Antibody Staining
6 pm-thick sections were cut and deparaffmized in Hemo-D for 10 minutes or
until paraffin was removed. Tissues were rehydrated by ethanol series. During
the embedding procedure, limbs were fixed in 4% paraformaldehyde. This
presented an autofluorescence problem that was overcome by treating the sections
with 0.1% sodium borohydride in PBS (pH 8.0) for 3 cycles at 10 minutes.
Saponin (Sigma) was used to add permeability to cell membranes, which enabled
antibodies to bind to the intracellular receptor complex. A mixture of 0.1%
saponin/10% goat serum/PBS pH 7.2 was made to dilute both primary and
secondary antibodies. Antibodies were purchased from Santa Cruz
Biotechnologies. Rabbit polyclonal antibodies for FGFR-1 (fig; epitope
corresponding to amino acids 808-822 at the carboxy terminal with no cross­
reactivity to bek, FGFR-3 or FGFR-4 as described by company) was used at a
1:30 dilution. FGFR-2 (bek; epitope corresponding to amino acids 789-802 at the
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carboxy terminus with no cross-reactivity to fig, FGFR-3 or FGFR-4 as described
by company) was used at a 1:30 dilution. These antibodies have been shown to
cross-react with amphibian systems, specifically in the newt (Notphthalmus
viridescens) and in the frog (Ranapipins) by McDevitt et al. (1997). Anti-rabbit
IgG conjugated with FITC (Fluorescein isothiocyanate; Vector Laboratories) was
used at a 1 GOO dilution for immunodetection. Negative controls for these
antibodies involved applying the secondary antibody to tissues without the
primary antibody. In addition, we performed positive tests for these antibodies on
newt tissues (regenerating eye and limb) and mouse testes.
Inhibitors
Six inhibitors, specific to FGFR-1 and FGFR-2, were used to characterize
the importance of these receptors in the process of limb regeneration.
Tyrophostin A-23 was purchased from Calbiochem (La Jolla, Ca) and 5 synthetic
oxindole-based inhibitors, namely SU5402, SU4984, SU76516, SU76636 and
SU76568 were provided by Dr. McMahon (from Sugen, Inc., San Francisco,
Ca). All inhibitors were made soluble in 100% dimethylsulfoxide (DMSO;
200pl), then mixed with water/food at approximately 250 ml (final
concentration=27 pM) per 30 animals. This concentration was determined from
previous in vivo in-lab experiments and in vitro studies with 3T3 cells
(Mohammadi et al., 1997). The pre-metamorphic (stage 53) animals were
immersed in inhibitor solution post-amputation and kept in this solution for 23
days after amputation. Since DMSO has been demonstrated to not affect the limb
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regeneration process at these concentrations, DMSO-treated controls were not
used (Tsonis et ah, 1994). This treatment was found to be the least toxic on the
animals.
At the end of the experiment, control (untreated premetamorphic hindlimbs)
and treated limbs were fixed in Bouin’s fixative (at least 24h). These limbs were
then rinsed in 70% alcohol and decalcified in 5% trichloroacetic acid (TCA) in
70% alcohol for 48 hours. The limbs then underwent dehydration by ethanol
series, were cleared and infiltrated with a 1:1 solution of 100% xylene: 100%
ETOH, embedded in paraplast and sectioned six-microns-thick onto pretreated
slides. Those limbs that underwent regeneration to the finger stage were whole
mount stained for cartilage with a 1% Victoria Blue B in 70% ethanol (Aldrich
Chemicals). These limbs were then stored in 100% methyl benzoate (Sigma
Diagnostics, St. Louis). Treated limbs that grew spikes, or did not match the
control group morphologically, were embedded and sectioned using a microtome
and stained with Harris hematoxylin modified solution and 1% eosin Y in 95%
ethanol (Sigma Diagnostics, St. Louis).
Victoria Blue Staining
Bouin’s fixative was removed from regenerated limbs with 2% ammonium
hydroxide solution for 48 hours with frequent changes. The limbs were immersed
in 10% hydrogen peroxide for depigmentation (time varies), dehydrated 1 hour in
50% and 1 hour in 70% ethanol and stained with 1% Victoria Blue B dissolved in
70% alcohol for 2 hours. The limbs were then de-stained via a graded ethanol
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series up to 95% ethanol until the stain was at a desired level. For storage, the
limbs were placed in methyl benzoate and pictures were taken by a CCD
videocamera viewed with an Olympus stereoscopic microscope.
Hematoxylin and Eosin Y Staining
Tissue sections were placed in 100% xylene until all wax was removed.
Tissues were hydrated with a graded ethanol series (100, 95, 75, 55, 35%) to tap
water. Once hydrated to tap water, tissues were place in hematoxylin until
sections began to appear blue (approximately 2 minutes). Tissues were
immediately rinsed in tap water to remove excess dye, then transferred back to
ethanol for dehydration up to 95% ethanol and placed in Eosin Y (diluted to 1%
in 95% ethanol) for a short time until desired pink color stain was obtained.
Tissues were washed in absolute ethanol, further dehydrated in 100% xylene and
a cover slide was mounted with 100% permount (Fisher Scientific, Pittsburgh).
Transplantation Experiment
30 tadpoles at stage 53 were amputated following surgical guidelines outlined
above and allowed to regenerate to an early cone (7 days). Wound epithelium
was carefully isolated from the regenerates and cultured for two days using
amphibian tissue media: 30% L-15, 30% Eagles medium, 9% fetal calf serum, 5%
conditional medium, 1% fungizone, 1% penicillin/streptomycin, 11.2 pg/ml
tenamycin, 15.0 pg/ml gentamycin, 10.0 pg/ml insulin, made in sterile de-
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ionized water. In order to assure that the isolated wound epithelium was
uncontaminated and that no mesenchymal cells were present, wound epithelium
was washed with serum free media (Sigma) two times and immersed in 10 pi Dil
(Indocarbocyanines; Molecular Probes, Indianapolis) in 1ml of serum free media
and allowed to incubate overnight. Dil is a cationic fluorescent dye that
accumulates on hyperpolarized membranes and translocates into the membrane of
the cultured tissue (Molecular Probes, cat., 1997). Three days prior to
transplantation, 20 post-metamorphic (stage 67-tailless) frogs were amputated at
the ankle of their hindlimbs as previously explained. Pre-metamorphic wound
epithelium was rinsed with serum free media two times and transplanted under
the first few cell layers of the healed wounds of 10 post-metamorphic frogs. The
remaining 10 frogs were used as control animals, in which, they were punctured
and treated as the experimental limbs, but no wound epithelium was transplanted.
Animals were allowed to grow and were observed for limb regeneration. Some
limbs were taken 2 weeks after implantation, imbedded in O.C.T. Compound
(Miles, Inc, IN) and processed for frozen sectioning using a cryostat. This was to
insure that the transplanted tissue had been incorporated and reorganized in the
host limb. These tissues were observed under fluorescence (rhodamine filter) and
bright-field microscopy. Intact limbs were viewed and captured by a CCD
videocamera and Sony printer.
O 'J
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Pictures
All black and white photos were taken with an Olympus camera connected to
either an Olympus BH-2 microscope or an Olympus SZ-PT stereoscopic
microscope. All color pictures were taken with a CCD videocamera (DEI-470,
Optronics Engineering, MI) connected to either an Olympus BH-2 microscope or
an Olympus SZ-P2 stereoscopic microscope, viewed with a Sony monitor and
printed with a Sony mavigraph videoprinter.
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RESULTS
Characterization of the stages of limb regeneration in Xenopus laevis.
The normal regenerative process in Xenopus laevis tadpole limbs amputated at
pre-metamorphic stage 53 (Nieuwkoop and Faber, 1976) as depicted through
histological sections. Regenerating limbs were taken at 3, 9, 12, 15, 18, 21 and
23 days post-amputation. The following will be a description through
observation of histological and morphological structures of the normal limb
regeneration process in Aenopwx laevis'.
Epithelial Wound Healing/Dedifferentiation- 3 days post-amputation. There is no
basal lamina formed and the wound epithelium is approximately two cell layers
thick as seen through electron microcopy (Dent, 1962).
Early Cone- (see fig. 2A) 5 to 10 days post-amputation. A blastema has been
formed without apparent differentiation.
Late Cone- 11 to 15 days post-amputation. Cartilage and muscle differentiation is
easily identifiable through light microscopy.
Early Palette- (See fig. 2B) 16 to 17 days post-amputation. The apical end of the
limb bud loses its conical shape and begins to flatten out. Muscles and cartilage
become more prominent.
Late Palette- (see fig. 2C) 18 to 19 days post-amputation. The flattened end of
the limb becomes more widespread and the wound epithelium thickens.
Early Toe- 20-27 days post-amputation. Toes begin to sprout from the palette.
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Late Toe- (see fig. 2D) 25 days post-amputation. Toes go through their final
stages of regeneration.
When Xenopus laevis was amputated at post-metamorphic stage 61
(Nieuwkoop and Faber, 1976); inspection at 15 days post-amputation indicates
that normal limb regeneration does not take place. Instead, there is the formation
of a cone (as shown in expression studies; fig. 3-7), then a spike containing
cartilagenous elements (not shown), which is identical to spikes presented from
inhibitor experiments (fig. 8D, IOC and D). The post-metamorphic re-growth is
also covered by a wound epithelium. However, as it will become apparent from
our data, this is molecularly different from the wound epithelium during pre-
metamorphic regeneration.
In situ hybridizations with xFGFRs in pre-metamorphic and post-
metamorphic hindlimb blastemas.
Sense and Antisense DIG labeled probes to xFGFR-1, 2, 3, 4a and 4b were used
for in situ hybridization studies with Xenopus laevis regenerating and non­
regenerating hindlimbs. Since the expression patterns at 3 days and 10 days were
the same as those shown at 15 days post-amputation, we present results from the
15 day pre-metamorphic and post-metamorphic hindlimb blastemas.
At 15 days post-amputation, regenerative blastemas from stage 53 tadpoles
(Nieuwkoop and Faber, 1976) are characterized as a late cone with a wound
epithelium that has a basal layer separating it from the underlying mesenchymal
36
cells. xFGFR-1 and xFGFR-2 expression was high in the wound epithelium and
mesenchyme and present in the surrounding cells of the perichondrium (fig. 3 A
and 4A, respectively). In post-metamorphic hindlimbs (stage 61), xFGFR-1 and
xFGFR-2 expression was absent from the wound epithelium, but exhibited some
expression to its underlying mesenchyme (Fig. 3B and 4B, respectively).
xFGFR-3 expression was seen in the wound epithelium, the mesenchymal cells
and in the cartilage condensations (Fig. 5A). Signal in post-metamorphic limbs
was present in both basal cell layer of the wound covering and the underlying
mesenchyme (Fig. 5B); however, when compared to the pre-metamorphic tissues,
expression was less prominent. xFGFR-4a was expressed in the wound
epithelium and mesenchyme in both the pre- and post-metamorphic hindlimbs
(Fig. 6A/B) and FGFR-4b exhibited moderate signal in the wound epithelium,
mesenchyme and in the perichondrium (Fig. 6C) of the pre-metamorphic limb.
Expression was seen in the wound epithelium basal cell layer and mesenchyme of
the post-metamorphic limb (Fig. 6D). Pre-metamorphic and post-metamorphic
hindlimb tissues presented with sense probes were used as negative controls and
were absent of expression (fig. 3B/D, 4B/D, 5B/D, FGFR4a and FGFR4b-not
shown).
Immunofluorescence with FGFR-1 and FGFR-2 presence in pre-
metamorphic and post-metamorphic hindlimb blastemas.
Although in situ hybridization results are conclusive to determine presence of
mRNA transcripts, immunohistochemistry is the more convincing technique to
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provide evidence that genes are truly being translated into proteins. We used two
primary rabbit polyclonal antibodies; one for FGFR-1 (fig) and another for
FGFR-2 (bek). Antibodies for FGFR-3, 4a and 4b were not available for the
amphibian system. Figure 7 depicts immunofluorescence staining of fig and bek
antibodies on paraffin sections of 15d regenerates from pre-metamorphic
regenerates and post-metamorphic non-regenerates as well as their respective
negative controls, fig (Fig. 7A) and bek (Fig. 7C) epitopes were present in both
the wound epithelium, its basal layer and underlying mesenchymal cells in the
pre-metamorphic regenerating limb; however, antibodies (fig and bek) did not
detect protein presence in post-metamorphic stumps (Fig. 7 B/D, respectively)
and the negative controls show low background (7E/F).
Effect of FGFR Inhibitors on Xenopus laevis limb regeneration.
In situ hybridization and immunofluorescence expression studies have indicated
that FGFR-1 and FGFR-2 are present in Xenopus laevis ’ pre-metamorphic
regenerative limbs (stage 53), but absent in post-metamorphic froglet non-
permissive limb stumps (stage 61). This demonstrates that FGFR-1 and FGFR-2 
might be important signaling molecules from the wound epithelium correlated
with the limb regeneration ability. In order to connect FGFR expression with a
function during limb regeneration, we have used Tyrophostin A-23 and 4
Oxindole based compound inhibitors (SU5402, SU4984, SU76568, SU76516 and
SU76636) to halt the FGFR signal transduction pathway.
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Tyrophostin-A23 is a broad range tyrosine kinase inhibitor, demonstrating its
ability to inhibit growth factor signal transduction in vitro (Yaish et el., 1988) and
its derivatives that are produced due to its instability in solution, have been shown
to inhibit FGF receptor signaling in vitro (Ramdas et ah, 1995). Oxindole-based
inhibitors have been shown to affect both FGFR-1 and FGFR-2.
After amputation, animals were separated into groups of 30 per tank and
treated with each inhibitor solution for 23 days, at which point we terminated this
experiment. We then compared the treatment effects on limb regeneration. These
results are presented in Table 2. Controls (untreated limbs) showed normal
regeneration and by 23 days they were at the toe stage (fig. 8A). However, in the
majority of the treated animals, regeneration was inhibited. Inhibition of the
regeneration was characterized by the presence of only a cone or spikes, which
are reminiscent of the outgrowth after amputation of post-metamorphic limbs.
Tyrophostin A-23 was capable of effecting the regeneration process in 74% of
limbs tested (Table 2; percentages represent the total # of limbs affected/total
limbs for each group). SU76568 had the most profound inhibiting effect on
regenerating limbs with a inhibition rate of 96%, followed by SU5402 at an
inhibition of 90%, while SU76516 showed inhibition in 89% of the limbs,
SU76636 in 82% and SU4984 in 68%. In the control group, we observed that
only 13% of the limbs were delayed, without apparent abnormalities.
The effects of inhibition on regeneration can be seen histologically in figures
8, 9 and 10. In figure 8, we compare representative regenerates (external view)
for different groups, taken at 23 days. In the control (untreated) regenerate, toes
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have re-grown (figure 8A). In figure 8B, we can observe a regenerate that has
been arrested at early cone stage due to treatment with SU4984. Figure 8C shows
a SU76516-treated regenerate at a late cone stage. A cartilagenous spike
reminiscent of post-metamorphic limbs developed after Tyrophostin A-23
treatment can be seen in Figure 8D.
In figure 9, we can observe abnormal limbs that regenerated to the toe stage,
stained with Victoria Blue B which stains cartilagenous elements. In Figure 9A,
we can observe the normal limb regenerate at 23d post-amputation. SU4984
caused a duplication at the level of the autopodium resulting in two sets of two
toes (Fig. 9B). SU76516 inhibited the normal formation in the tibia/fibula area
with a fusion of these bones (Fig. 9C). An example of a hypomorphic regenerate
induced by SU76516 is shown in Figure 9D.
Further inspection of inhibited regenerates or spikes through sectioning and
staining, demonstrated that the process of regeneration in the affected limbs was
not only simply delayed, but was altered considerably (Fig. 10). Figure 10A
shows a section through an untreated regenerate 7 days after amputation. This
early cone is characterized by the presence of a wound epithelium and blastema
formation. In figure 10B, we can observe a SU4984-treated regenerate 23 days
after amputation. A small cone has been developed with considerable
disorganization. This cone shows obvious abnormality in its polarity as well,
since this section shows a well-differentiated muscle (from stump), directly
underneath the cone. In figures 10C and 10D, we show the characteristic
histology of spikes with growth elements covered by a thin layer of epithelium.
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Tyrophostin A-23 treated limbs grew spikes (Table 2) which seemed to grow
almost immediately after treatment, producing a fairly large spike by 23 days
(IOC); whereas, other spikes, such as the one depicted in figure 10D produced by
treatment with SU4984 were shorter in length.
Transplantation of Xenopus laevis regenerating hindlimb wound epithelium
to non-regenerating post-metamorphic hindlimbs.
Our studies so far have indicated the importance of FGFR-1 and FGFR-2 in 
regulating limb regeneration. FGFR-1 and FGFR-2 were expressed in the wound 
epithelium during limb regeneration, but were absent from the wound epithelium 
in post-metamorphic, non-regenerating Xenopus laevis hindlimbs. In addition,
inhibitors affected limb regeneration. We have, therefore, deduced that the
wound epithelium must contain signals that are necessary for the onset of the limb
regeneration process. It is tempting to suggest that exogenous expression of 
FGFR-1 and FGFR-2 in the wound epithelium of post-metamorphic amputated 
hindlimbs should induce and restore limb regeneration in the Xenopus system. If 
this were true, it would solidify the importance of FGFRs in the limb regeneration 
process. Such a hypothesis can be pursued by creating transgenic Xenopus that 
would be capable of expressing these receptors in the wound epithelium of post- 
metamorphic limbs. Such experiments are feasible, but quite laborious, and 
therefore, beyond the scope of the present study. We, however, pursued some 
experiments which the wound epithelium from pre-metamorphic blastemas were
transplanted onto stumps of amputated post-metamorphic hindlimbs. We were
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interested in seeing if such a wound epithelium would provide the necessary
signals for the induction of limb regeneration. Indeed, we observed induction of
regeneration in a stage 67 froglet hindlimb after amputation and transplantation in 
two out of ten frogs. Figure 11A shows a regenerate 25 days after amputation; 
note the presence of toes connected by a web. Figure 1 IB depicts a section 
through a 14d stump of a stage 67 amputated hindlimb, transplanted with stage 53 
wound epithelium. The transplanted wound epithelium was treated with 1% Dil,
in order to visualize successful graft transplantation. Figure 11C is the same 
section stained with hematoxylin and eosin y viewed through a bright-field 
microscope.
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Figure 1:
Molecular Structure of FGFR Inhibitors
(A) Tyrophostin A-23; the structure contains benzylidenemalosine that
incorporates its phenyl moieties of tyrosine and compete for the tyrosine
kinase substrate site of protein tyrosine kinases.
(B) SU4984; the structure contains oxindole residues that contact the tyrosine
kinase at the site in which adenine of adenosine triphosphate binds, acting as
a competitive inhibitor.
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Figure 1: Molecular Structure of FGFR Inhibitors
A Tyrophostin A-23
£N
i
OH
3,4-ditrihydoxy-cis-cinnamonitrile
B SU4984 (example of Oxindole Based Compounds)
3-(4-(l-formylpiperazin-4-yI)-benzylidenyl)-2-indolinone
Figure 2:
Characterization of the stages of Limb Regeneration in Xenopus laevis.
Bright-field photographs taken with a stereoscopic microscope; 9x
magnification. Stage 53 Xenopus laevis regenerating hindlimbs at 7d (A),
14d (B), 18d (C) and 24d (D) post-amputation: (A) represents an early cone
(B) represents a late cone/early palette, (C) represents a late palette, (D)
represents a late finger regenerate.
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Figure 3:
In situ hybridizations with xFGFR-1 in pre-metamorphic and post-
metamorphic hindlimb blastemas. Paraffin sections through a Xenopus
laevis regenerating hindlimb blastema (stage 53,15 days post-amputation;
(A) Antisense and (C) Sense). xFGFR-1 shows expression in the wound
epithelium (we) and the mesenchyme (m). Paraffin sections through a
Xenopus laevis non-regenerating hindlimb blastema (Stage 61,15 days post­
amputation; (B) Antisense and (D) Sense). xFGFR-1 highly expresses only
in the mesenchymal tissue (m) but is absent from the wound epithelium(we).
Pictures were taken with a bright-field microscope (magnification at 400x)
by CCD videocamera.
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Figure 4:
In situ hybridizations with xFGFR-2 in pre-metamorphic and post-
metamorphic hindlimb blastemas. Paraffin sections through a Xenopus
laevis regenerating hindlimb blastema (stage 53,15 days post-amputation;
(A) Antisense and (C) Sense). xFGFR-2 is expressed in the wound epithelium
(we) and mesenchymal tissue (m), and perichondrium (p). Paraffin sections
through a Xenopus laevis non-regenerating hindlimb blastema (Stage 61,15
days post-amputation; (B) Antisense and (D) Sense). xFGFR-2 is absent
from the wound epithelium but is present in the mesenchyme (m). Pictures
were with a bright-field microscope (magnification at 400x) by CCD
videocamera.
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Figure 5:
In situ hybridizations with xFGFR-3 in pre-metamorphic and post-
metamorphic hindlimb blastemas. Paraffin sections through Xenopus laevis
regenerating hindlimb blastema (stage 53,15 days post-amputation; (A)
Antisense and (C) Sense; although cartilage cannot be seen, no presence was
detected in sense tissue). xFGFR-3 shows expression in the wound
epithelium (we), mesenchyme and in the cartilage condensations (c).
Paraffin sections through a Xenopus laevis non-regenerating hindlimb
blasrema (Stage 61,15 days post-amputation; (B) Antisense and (D) Sense).
xFGFR-3 shows expression in the mesenchyme and in the basal layer of the
wound epithelium (arrow). Pictures with a bright-field microscope
(magnification at 400x) by CCD videocamera.
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Figure 6:
In situ hybridizations with xFGFR-4a and xFGFR-4b in pre-metamorphic
and post-metamorphic hindlimb blastemas. Paraffin sections through a
Xenopus laevis regenerating hindlimb blastema (stage 53,15 days post­
amputation); xFGFR-4a shows high expression in the wound epithelium
(we), mesenchyme (m) and in the cartilage condensations (c). (B) Paraffin
sections of a Xenopus laevis non-regenerating hindlimb blastema (Stage 61,
15 days post-amputation); xFGFR-4a shows high expression in the wound
epithelium as well as its underlying mesenchyme (m). (C) Paraffin sections
through a Xenopus laevis regenerating hindlimb blastema (stage 53,15 days
post-amputation); xFGFR-4b shows expression in the wound epithelium
(we), mesenchyme (m) and around the perichondrium (p). (D) Paraffin
sections of a Xenopus laevis non-regenerating hindlimb (Stage 61,15 days
post-amputation); XFGFR-4b expression is present in the basal cell layer of
the wound epithelium and in the mesenchymal tissues. Pictures were with a
bright-field microscope (magnification at 400x) by CCD videocamera.
53

Figure 7:
Immunofluorescence: FGFR-1 and FGFR-2 presence in pre-metamorphic and
post-metamorphic hindlimb blastemas. (A) Paraffin sections through a
Xenopus laevis regenerating hindlimb blastema (stage 53,15 days post­
amputation); FGFR-1 (fig) shows high expression in the wound epithelium
(we), mesenchyme (m) and in the cartilage condensations (c). (B) Paraffin
sections of a Xenopus laevis non-regenerating hindlimb (Stage 61,15 days
post-amputation); FGFR-1 (fig) is absent from the wound epithelium (we)
as well as its underlying mesenchyme. (C) Paraffin sections through a
Xenopus laevis regenerating hindlimb blastema (stage 53,15 days post­
amputation); FGFR-2 (bek) shows expression in the wound epithelium (we)
only. (D) Paraffin sections of a Xenopus laevis non-regenerating hindlimb
(Stage 61,15 days post-amputation); FGFR-2 (bek) is absent from these
tissues. (E,F) Negative controls depicting paraffin sections through 15-day
Xenopus laevis hindlimb blastemas (stage 53 and stage 61, respectively).
Pictures were taken with a fluorescent microscope at a magnification of 200x.
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Figure 8:
Effects of Tyrophostin A-23 and Oxindole inhibitors on Xenopus laevis 
regeneration. Bright-field photographs taken of stage 53 Xenopus laevis 
regenerating hindlimbs at 23d post-amputation; all pictures were taken with
a stereoscopic microscope; 9x magnification. (A) represents a normal 
regenerated limb at 23 days post-amputation. (B) represents an early cone
when treated with SU4984 for 23 days post-amputation. (C) represents a late
cone when treated with SU4984 for 23 days post-amputation. (D) represents
a spike when treated with Tyrophostin A-23 for 23 days post-amputation.
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Figure 9:
Victoria Blue B cartilage staining of control and inhibited limbs.
23 day post-amputated Xenopus laevis regenerated limbs were stained with
Victoria Blue B, pictures taken by a CCD videocamera under stereoscopic
microscope at a magnification of 6x. (A) represents a normal regenerated
hindlimb (t; tibia, f; fibula). (B) represents a limb affected by SU4984; a
duplication (d) has occurred at the distal end of tibiafibularis region,
producing mirror image skeletal elements; note the tibiafibularis is fused
(fu). (C) represents a limb affected by SU76516; the limb has been fused (fu)
at the tibiafibularis region. (D) represents a limb affected by SU76636; the
limb has toe deformations (lack of growth) and abnormalities (a).
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Figure 10:
Effects of Tyrophostin A-23 and Oxindole-based inhibitors on Xenopus laevis 
regeneration (sections). Hematoxylin and Eosin Y stained paraffin sections. 
(A) represents a normal 7d regenerating early cone (400x); wound 
epithelium (we) is a few layers thick, cartilage condensations (c) are forming 
behind the mesenchymal tissues (m). (B) represents a SU4984-treated 23d 
regenerating early cone demonstrating tissue disorganization (200x). (C) 
represents a Tyrophostin A-23-treated 23d regenerative spike formed with
little evidence of muscle and skeletal elements (lOOx). (D) represents a
SU4894-treated 23d regenerative spike that is abnormal and with a smaller
form (lOOx). Pictures were taken under a bright-field microscope by a CCD
videocamera.
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Figure 11:
Transplantation of Xenopus laevis regenerating hindlimb wound epithelium 
to non-regenerating post-metamorphic amputated limbs offers patterned re 
growth: (A) represents re-growth in a stage 67 amputated hindlimb 
transplanted with stage 53 regenerative wound epithelium tissue after 25 
days taken by stereoscopic microscope (9x); re-growth is incomplete ( 3 
digits) and a web has formed. (B) represents a 14d stage 67 amputated 
hindlimb transplanted with stage 53 regenerative wound epithelium tissue 
conjugated with Dil dye taken by fluorescent microscope with a rhodamine 
filter (200x); the wound epithelium tissue has migrated and reorganized the
host tissue, (C) bright-field representation of (B) stained with hematoxylin
and eosin Y. Fluorescence and bright-field pictures were taken by CCD
videocamera.
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)le 2: Effects of Tyrophostin A-23 and Oxindole on Limb Regeneration
b Regeneration 
Srowth Stage
SU5402 SU4894 SU76636 SU76516 SU76568 Tyrophostin A-23 Controls
es 18 6 4 8 2 14 (
< Cone 23 12 8 7 13 16 I
Cone 15 10 11 10 11 10 !
< Palette 1 9 0 0 0 5 3’
Palette 2 1 3 0 1 5 3:
< Finger 2 1 2 2 0 2 2I
Finger 1 2 0 1 0 2 !
Total: 62 41 28 28 27 54 11:
90.32% 68.29% 82.14% 89.29% 96.30% 74.07% 12.50°/
Percentages=Total # of Early/Late/Spikes/Total Limbs
DISCUSSION
We have demonstrated that there are five FGF receptors that are present in the 
wound epithelium and underlying mesenchyme during Xenopus laevis limb 
regeneration (figures 3-7). xFGFR-1 and xFGFR-2 expression is absent from 
the wound epithelium in post-metamorphic hindlimb outgrowth when Xenopus
laevis loses its ability for normal limb regeneration (Figures 3B, 4B and 7B and
D). The expression patterns are consistent with what is known about FGFR
presence in developing and regenerating limbs.
In developing mouse limb buds, FGFR-1 (fig) expression is distributed in the
mesenchyme and its expression is related to the onset of newly differentiated
structures. FGFR-2’s (bek) expression surrounded the surface ectoderm as well
as the mesenchymal condensations, whereas FGFR-3 has been primarily found in
the cartilage rudiments of the limb and FGFR-4 in striated muscle (Orr-Urtreger
et al., 1991; Stark et al., 1991). In the regenerating newt limb, nvFGFR-1 was
highly expressed in the mesenchyme but not in the wound epithelium, and
nvFGFR-2, as well as its spliced variants bek and KFGR. were expressed in the
wound epithelium and mesenchyme (Poulin et al., 1993; Poulin and Chiu, 1995).
One difference between FGFR-1 expression between the newt and the frog is that
FGFR-1 is expressed in the Xenopus wound epithelium. This is probably a
species-specific difference between the two regenerating systems.
Clearly, the expression patterns for FGFR-1 and FGFR-2 presented in this
study suggest a role of these receptors in limb regeneration. However, the most
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convincing evidence that FGFRs are the regeneration signals is offered when pre-
metamorphic stage 53 tadpoles amputated limbs were treated with FGFR
inhibitors. After Xenopus laevis loses its ability to regenerate due to changes
occurring through metamorphosis, amputation thereafter results in a disorganized
cone or a cartilagenous spike. Our results demonstrate that morphologically
similar spikes are generated when FGFR inhibitors were used during the normal 
process of regeneration (Figures 8D, 10C-D). Since our expression analysis
showed that xFGFR-1 and xFGFR-2 were only present in the wound epithelium
of the pre-metamorphic regenerating limbs, we can deduce that the wound
epithelium does contain the regenerative signals linked to the FGF signaling 
pathway. Our preliminary transplantation studies support this and might provide
a meaningful extension in inducing regeneration in vertebrate models.
Our expression analysis with xFGFR-3, xFGFR-4a and xFGFR4b suggests
that these receptors are important in the maintenance of pre-metamorphic limbs.
xFGFR-3 expression in regenerating limbs seems to correlate with the developing
limb in its expression in cartilage formation. Since xFGFR-4a and 4b have not
been detected for presence in developing or regenerating limbs, our data might
suggest that they play roles in post-metamorphic spike formation.
Identifying the signal for regeneration is of paramount importance to the field.
For example, are these signals common in limb, eye, liver and tail regeneration?
Can the regenerative abilities in newts be unified under a molecular mechanism?
After lens removal in the newt, a regenerating lens appears to grow only from the
dorsal iris by dedifferentiation of pigmented epithelial cells (McDevitt, 1997).
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Interestingly, FGF and their receptors are expressed and control lens
differentiation (Robinson et al., 1995). Furthermore, FGFR-1 expression is
confined in the dorsal iris, and inhibition of its function with an FGFR-1 specific
inhibitor results in the arrest of lens regeneration (Del Rio-Tsonis et ah, 1997
unpublished). In this sense FGFR-1 seems as important for lens regeneration as
for limb regeneration. Comparative research, analogous to the one outlined in
this paper, can be extended to other regenerative systems, for example in mice,
which are capable of regenerating only their digit tips once amputated (Borgens,
1982; Mahmood et ah, 1995; Reginelli, et ah, 1995).
We have investigated signals that permit limb regeneration and have used
the Xenopus model because comparisons can easily be made between pre-
metamorphic tadpoles and post-metamorphic frogs. Our results provides
evidence that FGFR-1 and FGFR-2 are crucial factors involved in the induction of
limb regeneration. Extension of these studies to other models of regeneration and
animals through transgenesis might lead to the development of an animal system
where genetic manipulation is easier and can establish new models for
regeneration research.
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CONCLUSIONS
1. Through expression studies, we demonstrate that FGFR-1 and FGFR-2 show
patterns correlated with the induction ability of Xenopus to regenerate its
limbs.
2. Furthermore, by inhibiting FGFRs, we demonstrate that limb regeneration is
inhibited or shows characteristics as seen in post-metamorphic amputated
limbs.
3. These experiments point to a crucial role of wound epithelium signals in
regulating limb regeneration.
4. The wound epithelium is capable of inducing limb regeneration in post-
metamorphic limbs upon transplantation.
5. Extension of these studies in other animals or in the employment of transgenic
technologies could lead to new genetic models for limb regeneration.
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ABBREVIATIONS
a abnormal
AER apical ectodermal ridge
ATP adenosine triphosphase
BCIP bromochloroindoylphosphate
c cartilage condensations
DAG diacylglycerol
DEPC diethyl pyrocarbonate
DIG digoxigenin
DMSO dimethyl sulfoxide
ETOH ethyl alcohol
f fibula
FGF fibroblast growth factors
FGFR fibroblast growth factor receptors
FITC fluorescein isothiocyanate
GAG glycosaminoglycan
GTP guanosine triphosphate
HS heparin sulfate
IP3 inositol 1,4,5-triphosphate
m mesenchyme
mRNA messenger ribonucleic acid
NBT nitroblue tetrazolium
P periosteum
PBS phosphate-buffered-saline
PEG polyethylene glycol
PIP2 phosphatidylinositol 4,5,-bisphosphate
PLC phospholipase C
PTK protein tyrosine kinase
Tyr tyrosine
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